Saturday, August 2, 2014

Federal Judge Dismisses Dutrow Lawsuit

A federal judge has dismissed a lawsuit filed by trainer Rick Dutrow Jr. against the New York State Gaming Commission, the Association of Racing Commissioners International, and two New York regulators.

Dutrow, who had his license revoked for 10 years by the New York regulatory board, filed the suit against the New York State Racing and Wagering Board (predecessor to the Gaming Commission), John Sabini, who had served as chairman of the NYSRWB and RCI (as well as in other RCI roles); and NYSRWB members Daniel Hogan and Charles Diamond.


Read more on BloodHorse.com: http://www.bloodhorse.com/horse-racing/articles/86455/federal-judge-dismisses-dutrow-lawsuit#ixzz39Hx39D35

Fourth Question of the Day August 2, 2014 How many veterinarians have compounded medications made from bulk in violation of federal and in some cases state law sitting in their offices right now? How many are even aware they are violating the law?


US trainers including D. WayneLucus back race-day horse medication ban | WOPULAR

US trainers back race-day horse medication ban | WOPULAR

Third Question of the Day August 2, 2014 Should all organizations and groups involving horses adopt a rule that states: “For the purpose of this rule a forbidden substance should be considered any substance that is not FDA approved for equine use and prescribed by a licensed veterinarian? Why or why not?”


HORSE DOPING – SEGMENT 4 NONPROFIT DRUG TESTING PROGRAMS – PROS & CONS

 


By Rick Dennis
Aug. 1, 2014

In the article “Horse Doping – Segment 3,” I discussed whether or not nonprofit equine drug-testing programs were fair and balanced. In Segment 4, I will provide a brief history of employee drug-testing programs in a general comparison to equine nonprofit drug-testing programs, especially in lieu of the recent announcement of the Federation Equestre International (FEI) saying, “The human athlete is subject to drug testing in equine showing disciplines as well as the horse.”  This article will also detail the pros and cons of several nonprofit equine drug-testing policies in use in the industry today as well as the perceived short falls of each.

continue to read here

16 NRHA “MILLION-DOLLAR’ TRAINERS PROPOSE CHANGES TO NRHA DRUG POLICY--- Proposal Could Eliminate Compounded Animal Drugs--read: “For the purpose of this rule a forbidden substance should be considered any substance that is not FDA approved for equine use and prescribed by a licensed veterinarian.”

 

 

FROM THE EDITOR


By Glory Ann KurtzJuly 31, 2014The National Reining Horse Association (NRHA) is planning on putting into effect a new drug and medication policy in 2015 that is more in line with the Federation Equestre International (FEI) and the United States Equestrian Federation (USEF) – International events that the NRHA Open horses and riders compete in, including the Olympics. FEI is the leader with the others following suit, as they recently announced they can also test the “human athlete” at their shows.

THE TRAINER PROPOSAL
Recently 16 of the 19 well-known NRHA trainers, known by many as the “Million-Dollar Gang,” proposed a replacement to Section 7 Equine Medications, The Therapeutic Substance Provisions in the General Rules and Regulations of the NRHA Rule Book that was recently put into effect. These trainers are not disputing the method of collecting samples, but are disputing what a forbidden substance is.  Three of the Million-dollar Gang, who were from European countries, refused to join in on the proposed rule change.

continue to read here

Third Question of the Day August 2, 2014 Should the Federal Trade Commission take a more active role in advertsising by compounding pharmacies?


Second Question of the Day August 2, 2014 How many compounding pharmacies violate these IACP Guidelines for Marketing Compounded Medications Responsibly (Remember your state laws may be more strict on advertising)? How many in fact claim compounded medications are better than commerically available drugs or that commerically available drugs are bad for you (i..e., Disparaging other products, including manufactured drugs and synthetic hormones)

Imprimis Pharmaceuticals is Hiring a Regulatory Corporate Counsel

Regulatory Corporate Counsel


Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) is a San Diego-based specialty pharmaceutical company focused on the development and commercialization of proprietary and novel sterile and topical drug formulations. Certain of Imprimis’ patent-pending drug formulations are available today and are being prescribed by physicians. For more information, please visit www.imprimispharma.com
 Job Summary
Responsibilities will include counseling and reporting requirements on regulatory issues such as FDA and State Pharmacy laws and regulations, guidance documents relating to pharmaceutical advertising and promotion, scientific exchange, handling adverse events including regulatory actions and violations; and regulatory agency strategy on inspectional and safety issues, communications, and quality issues. Responsibilities also include counseling on fraud and abuse issues relating to sales and marketing activities, including the Anti-kickback Statute and False Claims Act, as well as contract and pricing strategies such as discounts, rebates, and bundling methodologies. Researches FDA, FTC, DEA, DOJ, CBP, and State BOP regulations, case law and statutes pertaining to regulatory agencies and the administrative process. Supports business processes concerning specific legal-FDA regulatory matters and issues. This position reports to the Vice President of Accounting and Public Reporting.
The successful candidate must have the demonstrated ability to build and maintain relationships, trust, and respect with clients and peers, as well as the ability to proactively identify and manage significant legal issues.  Strong leadership, technical knowledge, business acumen, and excellent communication skills are required. Candidate has a track record of effective decision-making and the proven ability to assess, calibrate, and effectively communicate legal risk.  You must have the managerial courage required to counsel senior leaders, manage relationships with outside counsel and several regulatory agencies, including but not limited to, state boards of pharmacy and the FDA, and provide effective coaching and constructive feedback, as well as the organizational savvy and diplomatic sensitivities necessary to effectively collaborate with cross-functional client teams.
Position Responsibilities: 
  • Correspond with the State Pharmacy Boards, FDA, other regulatory agencies, customers, suppliers, and division personnel as needed both orally and in writing to address regulatory inquires, problems, or requests.
  • Identify, recommend and implement where possible, corrective actions for regulatory and other related processes.
  • Review promotional information and product literature to ensure FDA and FTC regulatory compliance.
  • Review governmental rulings to determine changes and probable effects on facility activities.
  • Draft and negotiate a broad range of contracts related to all aspects of the organization, including license agreements, collaboration agreements, clinical trial agreements, sponsored research agreements, material transfer agreements, supply agreements, master services agreements, consulting agreements and confidentiality agreements.
  • Oversees legal services provided by the practice group and helps ensure consistency of legal advice on healthcare law issues, including healthcare fraud and abuse, FDA regulations on clinical trial conduct, labeling, advertising and pharmacovigilance, product liability, reimbursement, antitrust, privacy, and other matters relevant to the development, manufacture and commercialization of formulations and products.
  • Help execute and maintain HIPAA and security compliance across all business units
  • Collaborate with all necessary parties to achieve desired business outcomes, works closely with Vice President of Pharmacy Operations.
  • Excellent organization and time-management skills required. Must be able to manage heavy workload and aggressive timelines in a timely manner, prioritize and work under pressure.
  • Assist on other matters within the legal department as needed.
  • Perform duties in accordance with established company procedures and policies; perform other duties as assigned.
  • Coordinate with outside counsel as appropriate.
  • Develops and manages budgets for assigned legal matters.
  • Resolve contract disputes.
  • Contribute to the constant improvement of the internal contracting process.
Requirements: 
  • J.D. degree from an accredited law school, exceptional academic credentials and bar membership. Licensed to practice law in the United States and currently admitted to practice and in good standing as a lawyer in the state of California.
  • Licensed pharmacist preferred
  • 5 or more years of relevant experience in FDA regulatory law area and state boards of pharmacy
  • Knowledge of DQSA
  • Strong written, verbal and presentation communication skills.
  • Strong computer skills in database management and documentation preparation (Word, PowerPoint, Excel, and Microsoft Office) required.
  • Ability to think creatively in confronting new issues and pursuing novel approaches to old problems.
  • Ability to work under pressure, meet deadlines and exercise sound business judgment with critical thinking skills and high ethical standards.
  • Team player with a positive, can-do attitude.
  • Ability to complete tasks with little direction or need for supervisory follow-up.
  • Ability to travel up to 10% of the time. Must be able to travel independently as an Imprimis Pharmaceuticals, Inc. representative.
Work Environment/Physical Demands:
  • The employee may frequently be required to sit and talk or hear.
  • The employee is occasionally required to stand; walk; use hands to finger, handle, or feel; reach with hands and arms; climb or balance; stoop, kneel, crouch.
  • The employee must occasionally lift and/or move up to 25 pounds.
  • Specific vision abilities by this job include close vision, depth perception and ability to adjust focus.
Imprimis believes in creating long-term relationships by being responsive and relevant and by consistently delivering value to our community of customers. Specifically with our employees, we focus on attracting, developing and retaining the best talent for our business, challenging our people, demonstrating a “can-do” attitude and fostering a collaborative and mutually supportive environment.
Diversity creates a healthier atmosphere: All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, protected veteran status, or disability status.
Imprimis Pharmaceuticals, Inc. is a drug-free workplace. Candidates are required to pass a drug test before beginning employment. In addition, employees in certain positions are subject to random drug testing.

Question of the Day August 2, 2014 What duty ethically and legally does a compounding pharmacy employee have to report illegal compounding? Does it matter the title of the employee? For example PIC vs. acccountant vs. compounding sales or marketing representative? Who should be liable for false advertising? Who should be liable if illegal compounds are advertised, promoted and sold by the compounding pharmacy? Does it matter if the employee attends meetings of the compounding pharamcy and is allowed to freely speak his or her mind even though he or she is not an officer of the company? In other words doesn't a close relatonship with the officers of the companyeffect criminal and civil liabile of the employee?